478-28-4 Usage
Uses
Used in Pharmaceutical Industry:
Pseudoaspidin is used as an anticancer agent for its ability to suppress tumor growth and induce apoptosis in cancer cells. It is particularly effective in targeting the cell cycle, making it a potential candidate for cancer treatment.
Used in Antibacterial Applications:
Pseudoaspidin is used as an antibacterial agent due to its ability to inhibit bacterial growth, making it a valuable component in the development of new antimicrobial drugs and treatments.
Used in Insecticide Industry:
Pseudoaspidin is used as an insect-repelling agent for its ability to deter insects, which can be beneficial in the creation of natural and environmentally friendly insecticides.
However, despite its potential applications, Pseudoaspidin is not yet widely commercialized or synthesized on a large scale due to the complexity of its extraction from natural sources. Further research and development are needed to overcome these challenges and fully harness the benefits of Pseudoaspidin.
Check Digit Verification of cas no
The CAS Registry Mumber 478-28-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,7 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 478-28:
(5*4)+(4*7)+(3*8)+(2*2)+(1*8)=84
84 % 10 = 4
So 478-28-4 is a valid CAS Registry Number.
478-28-4Relevant academic research and scientific papers
Novel diphenylmethyl compounds having mycobacterium tuberculosis inhibitory activity
-
Paragraph 0270; 0271; 0286; 0381-0383, (2019/02/13)
The invention relates to novel diphenylmethyl derivatives having mycobacterium tuberculosis inhibitory activity and a preparation method thereof and particularly relates novel diphenylmethyl derivatives having activity for inhibiting replicative and non-replicating mycobacterium tuberculosis and a preparation method thereof. In particular, the invention relates to compounds shown in the formula (I) or all possible isomers, prodrugs, pharmaceutically acceptable salts, solvates or hydrates thereof, wherein the variables are as described in the specification. The invention also relates to the preparation method of the compounds and their pharmaceutical compositions and a use of the compounds in preparation of drugs for treating mycobacterium tuberculosis infection-caused diseases.
